(Q42211589)

18 October 2017

title

Adenovirus: current epidemiology and emerging approaches to prevention and treatment (English)

1 reference

18 October 2017

1 reference

1 reference

Uriel Sandkovsky

1

1 reference

18 October 2017

Luciano Vargas

series ordinal

2

1 reference

18 October 2017

Diana F Florescu

series ordinal

3

1 reference

18 October 2017

publication date

1 August 2014

1 reference

Current infectious disease reports

18 October 2017

published in

1 reference

18 October 2017

volume

16

1 reference

18 October 2017

issue

8

1 reference

18 October 2017

page(s)

416

1 reference

Adenoviruses in immunocompromised hosts

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection after pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infections in adult recipients of blood and marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infections in patients undergoing bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus Infection in Pediatric Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Long-term impact of respiratory viral infection after pediatric lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Respiratory viral infections within one year after pediatric lung transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infections in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection and treatment with cidofovir in children after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenoviral infections in pediatric liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infections in pediatric small bowel transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Enteric adenovirus infection in pediatric small bowel transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus infection in pediatric small bowel transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Opportunistic viral infections in intestinal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

What do we know about adenovirus in renal transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Hemorrhagic adenovirus cystitis after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

The impact of adenovirus infection on the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

A surveillance study of adenovirus infection in adult solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Diagnosis and treatment of adenovirus infection in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Antiadenovirus activities of several classes of nucleoside and nucleotide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenovirus in solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Adenoviral disease in pediatric solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

Emerging Infections: Adenovirus Infections in Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

High Levels of Adenovirus DNA in Serum Correlate with Fatal Outcome of Adenovirus Infection in Children after Allogeneic Stem‐Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11908-014-0416-Y

21 January 2018

12 December 2020

Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR

1 reference

12 December 2020

Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases

1 reference

12 December 2020

Adenovirus enterocolitis in human small bowel transplants

1 reference

12 December 2020

Adenovirus infections in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

1 reference

12 December 2020

Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease

1 reference

12 December 2020

Association of viral genome with graft loss in children after cardiac transplantation

1 reference

12 December 2020

Viral infections in pediatric bone marrow transplant patients

1 reference

12 December 2020

Infectious enteritis after intestinal transplantation: incidence, timing, and outcome

1 reference

12 December 2020

Respiratory virus infection in immunocompromised patients

1 reference

12 December 2020

Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections

1 reference

12 December 2020

Prediction of severe disseminated adenovirus infection by serum PCR

1 reference

12 December 2020

In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.

1 reference

12 December 2020

Adenovirus infection in the lung results in graft failure after lung transplantation

1 reference

12 December 2020

Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery

1 reference

12 December 2020

Increasing incidence of adenovirus disease in bone marrow transplant recipients

1 reference

12 December 2020

Adenovirus pneumonia in lung transplant recipients

1 reference

12 December 2020

Adenoviral infections in pediatric transplant recipients: a hospital-based study

1 reference

12 December 2020

Virus Infections and Acute Renal Transplant Rejection

1 reference

12 December 2020

10.1007/S11908-014-0416-Y

Identifiers

DOI

1 reference

18 October 2017

1 reference